In CSF, BD1 concentrations were not associated with increased risk of dementia, while selenoprotein P concentrations based on the AA3 assay were moderately and positively associated with dementia risk above the reference point of 30 ng/mL, with an almost linear pattern above this cutpoint. This evidence concerns the gene SELENOP and dementia.